AUTL peer analysis
Autolus Therapeutics (AUTL) against its competitors: price, today's move, 1-year return and market value side by side.
- AUTL's peers: ALLO (Allogene Therapeutics), ATRA (Atara Biotherapeutics), CLLS (Cellectis), CRBU (Caribou Biosciences), DTIL (Precision BioSciences), FATE (Fate Therapeutics), IPSC (Century Therapeutics), LEGN (Legend Biotech).
AUTL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALLO Allogene Therapeutics | $0.63 | -4.83% | -49.63% | $219.90M |
| ATRA Atara Biotherapeutics | $6.34 | -6.35% | -53.86% | $64.59M |
| CLLS Cellectis | $0.98 | -4.49% | -77.64% | $99.10M |
| CRBU Caribou Biosciences | $0.30 | -4.86% | -83.77% | $31.91M |
| DTIL Precision BioSciences | $7.40 | 7.09% | 53.53% | $206.72M |
| FATE Fate Therapeutics | $0.96 | -5.06% | -8.68% | $116.57M |
| IPSC Century Therapeutics | $1.16 | -12.46% | 123.54% | $209.84M |
| LEGN Legend Biotech | $15.44 | -4.10% | -44.86% | $2.86B |
| LYEL Lyell Immunopharma | $13.80 | 1.62% | -19.86% | $339.28M |
| MBIO Mustang Bio | $0.37 | -2.63% | -69.17% | $2.49M |
| AUTL Autolus Therapeutics | $0.92 | -6.08% | -27.56% | $245.03M |